Amitriptyline vs nomifensine
Seizure frequency · people with epilepsy and depression
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
19 questions · 19 findings · 2 reviews
No studies found 6 · 31.6%GRADE not reported 6 · 31.6%Very low 6 · 31.6%Low 1 · 5.3%Moderate 0 · 0%High 0 · 0%
Amitriptyline vs nomifensine
Treatment withdrawal · people with epilepsy and depression
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Amitriptyline vs nomifensine
Cognitive function · people with epilepsy and depression
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Amitriptyline vs nomifensine
Quality of life · people with epilepsy and depression
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Amitriptyline vs nomifensine
Adverse effects · people with epilepsy and depression
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Amitriptyline vs nomifensine
> 50% reduction in depressive symptoms · people with epilepsy and depression
Amitriptyline showed no clear difference in > 50% reduction in depressive symptoms compared with nomifensine (low certainty).
1 finding from 1 review
- RR 0.55 [0.28, 1.06]1 study · 28 participantsLow
Amitriptyline vs nomifensine
Mean depression scores · people with epilepsy and depression
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Amitriptyline vs gabapentin
Participant‐reported pain relief of 30% or greater · children and adolescents with chronic non‐cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Amitriptyline vs placebo
Adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 123 participantsVery low
Amitriptyline vs placebo
Serious adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 123 participantsVery low
Amitriptyline vs placebo
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 123 participantsVery low
Amitriptyline vs gabapentin
Participant‐reported pain relief of 50% or greater · children and adolescents with chronic non‐cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Amitriptyline vs gabapentin
Patient Global Impression of Change much or very much improved · children and adolescents with chronic non‐cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Amitriptyline vs gabapentin
Adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 34 participantsVery low
Amitriptyline vs gabapentin
Serious adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 34 participantsVery low
Amitriptyline vs gabapentin
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 34 participantsVery low
Amitriptyline vs placebo
Participant‐reported pain relief of 30% or greater · children and adolescents with chronic non‐cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Amitriptyline vs placebo
Participant‐reported pain relief of 50% or greater · children and adolescents with chronic non‐cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Amitriptyline vs placebo
Patient Global Impression of Change much or very much improved · children and adolescents with chronic non‐cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
- Antidepressants for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found